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Introduction
Community-acquired pneumonia (CAP) is one of the primary 
causes of sepsis, septic shock, acute respiratory distress 
syndrome (ARDS), and multiple organ dysfunction syndrome 
(MODS) [1-3]. The chain of immune responses in patients 
with pneumonia can be considered as a continuum of disease 
from an initial appropriate response in patients with CAP, 
to a deleterious response that encompasses Severe CAP, 
Sepsis, Septic Shock, ARDS and MODS. As the lung infection 
overwhelms the natural defenses that are produced by 
physiologic pulmonary and systemic inflammation, a deeper 
line of defense is necessary. At this point, the immune system 
may develop an inflammatory response that may be damaging 
to vital organs, culminating with organ failure. In this opinion 
piece I will review the pathophysiology of CAP and construct a 
continuum of disease from CAP to MODS.  
Pathophysiology of CAP
In a prior opinion piece in the Journal of Respiratory Infections, 
I stated that the pathogenesis of CAP is evolving as we recognize 
that the lower respiratory tract is not sterile as we previously 
considered [4]. A schematic representation of the alveolar 
space, containing the alveolar macrophage as well as the 
normal alveolar flora, is depicted in Figure 1. The concept that 
organisms should first arrive to the alveoli as the first step in 
the pathogenesis of CAP may not be necessary in all patients. 
Multiplication of bacteria or viruses already present in the 
alveoli, as part of the normal flora, may be an important etiology 
of CAP. The traditional typical and atypical pathogens able to 
cause CAP are not considered as part of the normal alveolar flora. 
For these organisms, the first step in the pathogenesis of CAP is 
their arrival to the alveolar space primarily via microaspiration 
of oropharyngeal secretions (Figure 2).  
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Figure 2. Arrival of S. pneumoniae to the alveolar space via 
microaspiration of oropharyngeal secretions.
Figure 1. A schematic representation of the alveolar space, containing 
the alveolar macrophage as well as the normal alveolar flora.
The alveolar macrophages are professional phagocytes 
that represent an important defense mechanism against 
multiplication of organisms at the alveolar level.  The normal 
alveolar flora may have a defensive role against respiratory 
pathogens. If these defense mechanisms fail to contain the 
local multiplication of organisms, the macrophage will produce 
a series of cytokines to bring new phagocytes to the alveolar 
space (Figure 3). Alveolar epithelia cells are likely involved in 
the production of local cytokines in the context of pneumonia. 
Local production of cytokines will generate an inflammatory 
response with increased local microvascular permeability. 
This will facilitate the movement of neutrophils, lymphocytes, 
dendritic cells, red blood cells, platelets, proteins, and fluid 
into the alveolar space. The presence of this alveolar exudate 
will aid the macrophages in the killing of alveolar pathogens. 
This process characterizes the initial pulmonary inflammatory 
response or local inflammatory response (Figure 4). 
As a consequence of the local production of cytokines and 
chemokines, these mediators will spill into the systemic 
circulation and serve as a way for the lung to communicate 
with a series of organs such as the liver, bone marrow, brain, 
and spleen. During these interactions, the lung will submit 
and receive inputs and generate an integrated systemic 
inflammatory response. The liver will produce an acute phase 
response, characterized primarily by hepatocyte production of 
C-reactive protein. The bone marrow will produce neutrophils 
and other cells necessary to migrate into the alveolar space. 
The brain thermoregulatory center will elevate the body 
temperature. The spleen will produce the appropriate 
immunoglobulins according to the antigenic characteristics of 
the pulmonary pathogen. All of this lung orchestrated local and 
systemic inflammatory responses are considered a normal host 
physiologic response to the growth of pathogenic organisms in 
the alveolar space (Figure 5). The physiologic abnormalities 
produced by the local and systemic host inflammatory response 
will explain most of the clinical and laboratory abnormalities in 
patients with pneumonia. 
Pathophysiology of CAP with Sepsis
In some patients the initial physiologic systemic inflammatory 
response can become dysregulated. This abnormal response 
will be associated with tissue injury and organ dysfunction. 
The progression from a physiologic to a dysregulated systemic 
inflammatory response indicates that pneumonia is now 
complicated with sepsis [5]. When a patient with CAP develops 
sepsis, the patient will have a more severe clinical picture. From 
a pathogenesis point of view, it can be considered that when a 
patient with CAP advances to sepsis, then the patient has severe 
CAP (Figure 6).
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Figure 3. Alveolar macrophage phagocytosis of S. pneumoniae and 
production of cytokines and chemokines.
Figure 4. Alveolar macrophage phagocytosis of S. pneumoniae and 
production of cytokines and chemokines.
Figure 5. The physiologic host local and systemic response characterize 
patients with mild to moderate CAP.
Figure 6. The host dysregulated inflammatory response indicates that 
the patient develops sepsis. At this point the patient is consider to have 
Severe CAP.
Pathophysiology of CAP with Septic 
Shock, ARDS, and MODS 
In some patients with CAP, the levels of inflammatory mediators 
that are produced with the intention to damage the pathogenic 
organisms in the lung, produce significant tissue damage. 
This may represent a tradeoff of the immune response in 
patients with persistent microbial challenge. Dysfunction of the 
cardiovascular system will manifest as hypotension and septic 
shock. Dysfunction of the pulmonary parenchyma beyond the 
area of CAP will manifest as ARDS. Progression to dysfunction 
of multiple other organs and systems will manifest as MODS 
(Figure 7).  
Conclusions
In this opinion piece I categorized patients with CAP as a 
continuum of disease using a pathophysiologic approach. 
Patients with CAP of mild or moderate severity have an 
appropriate pulmonary and systemic inflammatory response. 
If this physiologic response failed to control the pulmonary 
infection, the immune system compromises. On one hand, 
the immune system produces an exaggerated inflammatory 
response in an attempt to control the pulmonary infection, on 
the other hand, the same inflammatory response will produce 
organ dysfunction. At this point the patient will have a clinical 
picture of severe CAP and will have evidence of sepsis. Patients 
with CAP and a persistent dysregulated inflammatory response 
may develop septic shock, ARDS, or MODS. Categorizing the 
severity of CAP using a pathophysiologic approach may help us 
to better study new treatment strategies.
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Figure 7. Progression of the dysregulated inflammatory response will 
present clinically as a patient with severe CAP plus septic shock, and/or 
ARDS, culminating with MODS.
